Indications
After radiolabelling with sodium pertechnetate (99mTc) solution, the solution obtained is indicated for

  • Primary bone tumours imaging
  • Bone metastases of other tumours (e.g. prostate, breast, lung cancer)
  • Osteomyelitis
  • Metabolic bone disease
  • Paget’s disease
  • Fractures
  • Avascular necrosis
  • Loosened/inflamed arthricular prosthesis
  • Arthricular inflammations (rheumatoid arthritis).

Labelling activity
Up to 10 GBq (270.3 mCi)

Shelf life
24 months

Shelf-life and storage conditions after radiolabelling
8 hours, Do not store above 25°C.

Medi-RadioPharma is a long-established producer and distributor of radiopharmaceuticals, sealed radiation sources, and calibration standards for nuclear medicine, research, and industrial applications. With a portfolio covering diagnostic and therapeutic isotopes, generators, and custom-made radioactive preparations, Medi-RadioPharma serves hospitals, laboratories, and industrial partners across international markets.

Through its partnership with Van Overeem Nuclear B.V., Medi-RadioPharma enhances its service offering: Van Overeem’s Sources Made Easy concept provides customers with convenient multi-annual agreements for the delivery of new sources and the safe disposal of depleted ones, fully tailored to departmental needs.

Together, Medi-RadioPharma and Van Overeem Nuclear B.V. deliver a comprehensive, reliable solution for isotope supply, logistics, and lifecycle management — ensuring high-quality, compliant support for medical imaging, therapy, research, and industrial processes.